
149 Medical Inc Profile last edited on: 1/30/2020
CAGE: 81CV8
UEI: P3CACVT5FJG6
Business Identifier: Medical device to reduce potential disability in preterm newborns patients Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 03
County: Worcester
Congr. District: 03
County: Worcester
Public Profile
There is currently no device/technology that allows for continuous monitoring of brain hemodynamics (blood flow and metabolism) - a deficiency that is particularly crucial in the neonatal ICU where long term negative outcomes such as cerebral palsy and intellectual disability are driven by injuries to the brain due to the immature cardiovascular system and under-/over-treatment. Intended to to reduce disability in preterm newborns patients, the device being developed by 149 Medical is designed to be the first non-invasive monitor that measures real-time brain hemodynamics and metabolism, second by second. The system provides early actionable alerts and continuous feedback allowing for early intervention and treatment monitoring.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2022 | 2 | NIH | $773,802 | |
Project Title: Development and evaluation of diffuse correlation spectroscopy to monitor cerebral blood flow and detect intraventricular hemorrhage in extremely premature infants |
Key People / Management
Antoniu Fantana -- Co-Founder, President and CEO
Bernhard Zimmermann -- Co-Founder
Bernhard Zimmermann -- Co-Founder
Company News
There are no news available.